Suchergebnisse - "Nava, Susana"

PubPharm (7)

1

LVS ΔcapB-vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice

enthalten in: mBio | 2024

von Tullius, M. | Bowen, R. | Back, P. | +3

2

Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge

enthalten in: Communications biology | 2022

von Jia, Q. | Masleša-Galić, S. | Nava, S. | +1

3

Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice

enthalten in: mBio | 2022

von Jia, Q. | Masleša-Galić, S. | Nava, S. | +1

4

PPE37 Is Essential for Mycobacterium tuberculosis Heme-Iron Acquisition (HIA), and a Defective PPE37 in Mycobacterium bovis BCG Prevents HIA

enthalten in: Infection and immunity | 2019

von Tullius, M. | Nava, S. | Horwitz, M.

5

Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs

enthalten in: PloS one | 2019

von Clemens, D. | Lee, B. | Silva, A. | +6

ErratumIn: PLoS One. 2019 May 30;14(5):e0217670. - PMID 31145763

6

Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibility

enthalten in: PloS one | 2018

von Lee, B. | Clemens, D. | Silva, A. | +5

7

Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time

enthalten in: Nature communications | 2017

von Lee, B. | Clemens, D. | Silva, A. | +6

1
[1]